Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epstein-Barr Virus Nuclear Antigens | 3 | 2013 | 157 | 1.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 886 | 0.520 |
Why?
|
| Viral Proteins | 3 | 2013 | 1802 | 0.510 |
Why?
|
| Trypanosoma cruzi | 4 | 2003 | 206 | 0.450 |
Why?
|
| Urinary Bladder | 1 | 2019 | 1166 | 0.420 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2011 | 28 | 0.380 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2011 | 33 | 0.380 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 121 | 0.370 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2013 | 1356 | 0.340 |
Why?
|
| Herpesvirus 4, Human | 2 | 2012 | 1075 | 0.320 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2011 | 438 | 0.310 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2019 | 2277 | 0.270 |
Why?
|
| Protein Sorting Signals | 1 | 2006 | 279 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 5784 | 0.250 |
Why?
|
| Urinary Diversion | 1 | 2023 | 135 | 0.210 |
Why?
|
| Genes, Protozoan | 1 | 2003 | 166 | 0.210 |
Why?
|
| Protozoan Proteins | 3 | 2003 | 838 | 0.200 |
Why?
|
| Histone Deacetylases | 1 | 2006 | 718 | 0.200 |
Why?
|
| Gastroscopy | 1 | 2023 | 209 | 0.200 |
Why?
|
| Ureter | 1 | 2023 | 375 | 0.180 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2020 | 43 | 0.170 |
Why?
|
| Gossypol | 1 | 2019 | 23 | 0.170 |
Why?
|
| Fowlpox virus | 1 | 2019 | 21 | 0.170 |
Why?
|
| Administration, Intravesical | 1 | 2019 | 92 | 0.170 |
Why?
|
| Arginine | 1 | 2003 | 934 | 0.160 |
Why?
|
| Serine | 1 | 2003 | 831 | 0.160 |
Why?
|
| Hepatitis | 1 | 2021 | 231 | 0.160 |
Why?
|
| Oncolytic Viruses | 1 | 2022 | 343 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2013 | 4739 | 0.150 |
Why?
|
| RNA Splicing | 1 | 2003 | 914 | 0.150 |
Why?
|
| Enteral Nutrition | 1 | 2023 | 781 | 0.140 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2019 | 275 | 0.140 |
Why?
|
| Carboplatin | 1 | 2019 | 789 | 0.130 |
Why?
|
| Kidney Transplantation | 2 | 2023 | 4215 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2006 | 2978 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 11902 | 0.130 |
Why?
|
| Hydroxychloroquine | 1 | 2019 | 428 | 0.120 |
Why?
|
| Maximum Tolerated Dose | 3 | 2023 | 877 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2013 | 12100 | 0.110 |
Why?
|
| Callithrix | 1 | 2013 | 93 | 0.110 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 7593 | 0.110 |
Why?
|
| Melanoma | 2 | 2022 | 5695 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2019 | 1738 | 0.100 |
Why?
|
| Receptors, Complement 3d | 1 | 2011 | 117 | 0.090 |
Why?
|
| Schizosaccharomyces | 2 | 2003 | 237 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 859 | 0.090 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 6543 | 0.090 |
Why?
|
| Sequence Alignment | 3 | 2003 | 2178 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 10829 | 0.090 |
Why?
|
| Cell Line | 3 | 2013 | 15626 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1856 | 0.090 |
Why?
|
| Pneumonia | 1 | 2021 | 2138 | 0.080 |
Why?
|
| Cell Transformation, Viral | 1 | 2011 | 526 | 0.080 |
Why?
|
| Receptors, IgE | 1 | 2011 | 377 | 0.080 |
Why?
|
| Immediate-Early Proteins | 1 | 2012 | 449 | 0.080 |
Why?
|
| Graft Survival | 1 | 2018 | 3793 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2811 | 0.080 |
Why?
|
| Neoplasms | 3 | 2023 | 22066 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2003 | 3105 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2698 | 0.070 |
Why?
|
| Cell Fractionation | 1 | 2006 | 251 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 2469 | 0.070 |
Why?
|
| 14-3-3 Proteins | 1 | 2006 | 221 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 5333 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2023 | 11708 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2012 | 2195 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 1137 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 1120 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2006 | 565 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 877 | 0.060 |
Why?
|
| Genomics | 1 | 2020 | 5790 | 0.060 |
Why?
|
| Ureterostomy | 1 | 2023 | 18 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5640 | 0.060 |
Why?
|
| Riluzole | 1 | 2023 | 58 | 0.050 |
Why?
|
| DNA, Protozoan | 2 | 2003 | 228 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13456 | 0.050 |
Why?
|
| Goats | 1 | 2022 | 167 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4717 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2012 | 2861 | 0.050 |
Why?
|
| Globins | 1 | 2003 | 403 | 0.050 |
Why?
|
| Animals | 7 | 2022 | 167940 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2414 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2003 | 568 | 0.050 |
Why?
|
| Niacinamide | 1 | 2023 | 414 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 4172 | 0.050 |
Why?
|
| Gastrostomy | 1 | 2023 | 321 | 0.050 |
Why?
|
| Humans | 17 | 2023 | 760261 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 2023 | 529 | 0.040 |
Why?
|
| DNA | 2 | 2011 | 7236 | 0.040 |
Why?
|
| Species Specificity | 1 | 2003 | 2413 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2755 | 0.040 |
Why?
|
| Device Removal | 1 | 2023 | 634 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 321 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9388 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2019 | 730 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13249 | 0.030 |
Why?
|
| Transplants | 1 | 2018 | 206 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 884 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3800 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9468 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 1884 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2003 | 17628 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2019 | 966 | 0.030 |
Why?
|
| Middle Aged | 4 | 2019 | 220175 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1408 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 9590 | 0.020 |
Why?
|
| Autophagy | 1 | 2019 | 1336 | 0.020 |
Why?
|
| Response Elements | 1 | 2012 | 308 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 16905 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 2866 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3826 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 168995 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 453 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2018 | 2314 | 0.020 |
Why?
|
| Motivation | 1 | 2018 | 1990 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 3726 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 491 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 2311 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2012 | 658 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7072 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 9196 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 8018 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 1412 | 0.020 |
Why?
|
| Male | 5 | 2021 | 359413 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11141 | 0.010 |
Why?
|
| Virus Replication | 1 | 2012 | 2431 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8498 | 0.010 |
Why?
|
| RNA, Protozoan | 1 | 2003 | 45 | 0.010 |
Why?
|
| Apoptosis | 1 | 2019 | 9497 | 0.010 |
Why?
|
| Binding Sites | 1 | 2012 | 6050 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 458 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9274 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 80301 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 13967 | 0.010 |
Why?
|
| Adult | 3 | 2020 | 219847 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 26168 | 0.010 |
Why?
|
| Female | 4 | 2020 | 391011 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1999 | 234 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29636 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1999 | 418 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 285 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39254 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 1999 | 360 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 25928 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1999 | 586 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41317 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2003 | 1892 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 54263 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 58673 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64947 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 5039 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 87747 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 2424 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 1999 | 3107 | 0.000 |
Why?
|
| Mutation | 1 | 2012 | 29950 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 5793 | 0.000 |
Why?
|
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_